Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology and diagnostic company, today announced its wholly owned subsidiary, Enzo Clinical Labs, Inc., has expanded its screening services for COVID-19. Following the company’s March 6, 2020 announcement regarding the initiation of accepting specimens for novel Coronavirus (COVID-19) testing, Enzo is now directly collecting specimens at a drive-through facility by appointment in Enzo’s laboratory complex in Farmingdale, New York. This facility has been set up with support from local and state officials.

As one of the first independent drive-through testing facilities on Long Island, NY, it is easily accessible for Nassau and Suffolk County residents and is now in operation. The goal of this testing site is to help the local community improve virus surveillance and reduce pressure on the regional hospital systems.

Enzo President Barry Weiner commented: “Enzo understands and takes seriously its responsibility as a leading and resourceful diagnostic and clinical laboratory to help alleviate the present bottleneck existing around COVID-19 testing in the communities we serve during this rapidly evolving pandemic environment. We are partnering with State and Local officials to bring access and availability to the nearly eight million people in the underserved Long Island, New York, communities. Our technical staff is committed to do what it takes in providing necessary patient care. We appreciate the government and public support that has enabled Enzo to quickly establish this facility and continue to serve the Long Island community with the highest standards. We also are exploring how we can apply our many years of technical know-how and manufacturing experience to contribute to testing alternatives.”

To receive testing, patients who are concerned that they or a family member are exhibiting symptoms of COVID-19 must initially consult a physician. If directed by the physician, the patient will receive a prescription (“script”) with which the patient can make an appointment by phone for COVID-19 testing at the Farmingdale facility. Once the patient arrives at the scheduled time for the appointment, he/she will remain in their car and must present a photo-ID for verification as well as any other necessary documentation. A healthcare professional with protective gear will collect a sample using a nasal swab (similar to a flu test). The specimen will be sent to Enzo’s clinical laboratory facility for processing, and test results will be available in a timely manner through the ordering physician or, by request, directly to the patients.

Further information is available on Enzo’s website at: http://www.enzoclinicallabs.com/coronavirus